Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mycophenolate Mofetil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 known ✓ | P12268 | 19/20 | 0.70 |
| ▸ | IMPDH1 known ✓ | P20839 | 14/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.63 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mycophenolate Mofetil SCHEMBL29645056 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL29378681 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL28390 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL29571382 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL218782 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL23581135 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL10262894 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL1235420 | 0.99 | ALDH1A1 (0.98) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL2257852 | 0.99 | ALDH1A1 (0.98) | ALDH1A1LMNAHPGDABCC4NR1I2 | |
| Mycophenolate Mofetil SCHEMBL3016437 | 0.99 | ALDH1A1 (0.98) | ALDH1A1LMNAHPGDABCC4NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 54614 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144816-A1 | COMPOSITIONS AND METHODS FOR TREATING DEMENTIA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-05-28 | — | — | US | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4749286-A2 | METHOD OF ASSESSING RISK OF PML | Biogen MA Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| US-12636319-B2 | Pharmaceutical composition for preventing or treating atopic disease containing Akkermansia muciniphila strain | ENTEROBIOME INC. (KR) | 2026-05-26 | — | — | US | claimed |
| US-20260141455-A1 | LOCATION BASED DATABASE SYSTEM DASHBOARDS | EXPRESS SCRIPTS STRATEGIC DEV INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026107075-A1 | METHODS OF TREATING MULTIPLE SCLEROSIS WITH CD19-CD20 DUAL CAR-T CELLS | GENENTECH, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026104987-A1 | REMIBRUTINIB FOR USE IN THE TREATMENT OF MYASTHENIA GRAVIS | NOVARTIS AG (CH) | 2026-05-21 | — | — | WO | claimed |
| US-20260137680-A1 | NOVEL COMPOUNDS | SITRYX THERAPEUTICS LTD (GB) | 2026-05-21 | — | — | US | claimed |
| WO-2026103922-A1 | CHIMERIC SHUTTLING RECEPTOR | 深圳市湾岛细胞科技有限公司 | 2026-05-21 | — | — | WO | claimed |
| EP-0697866-A1 | HIGH DOSE FORMULATIONS | SYNTEX (U.S.A.) INC. (US) | 1996-02-28 | — | — | EP | claimed |
| WO-1996002004-A1 | IMMUNOASSAY FOR MYCOPHENOLIC ACID | BEHRINGWERKE AG (DE) | 1996-01-25 | — | — | WO | claimed |
| US-5455045-A | Active agent of mycophenolate mofetil and mycophenolic acid; liquefying by melting, cooling, filling into dosage form; oral administration; Penicillium; immunosuppressant drugs | SYNTEX (U.S.A.) INC. (US) | 1995-10-03 | — | — | US | claimed |
| EP-0670724-A1 | USE OF MYCOPHENOLIC ACID, MYCOPHENOLATE MOFETIL OR DERIVATE THEREOF TO INHIBIT STENOSIS | SYNTEX (U.S.A.) INC. (US) | 1995-09-13 | — | — | EP | claimed |
| EP-0649422-A1 | DIRECT ESTERIFICATION OF MYCOPHENOLIC ACID. | SYNTEX INC (US) | 1995-04-26 | — | — | EP | claimed |
| WO-1995009626-A1 | MYCOPHENOLATE MOFETIL HIGH DOSE ORAL SUSPENSIONS | SYNTEX (U.S.A.) INC. (US) | 1995-04-13 | — | — | WO | claimed |
| WO-1994026266-A1 | HIGH DOSE FORMULATIONS | SYNTEX (U.S.A.) INC. (US) | 1994-11-24 | — | — | WO | claimed |
| WO-1994012184-A1 | USE OF MYCOPHENOLIC ACID, MYCOPHENOLATE MOFETIL OR DERIVATE THEREOF TO INHIBIT STENOSIS | SYNTEX (U.S.A.) INC. (US) | 1994-06-09 | — | — | WO | claimed |
| WO-1994001427-A1 | DIRECT ESTERIFICATION OF MYCOPHENOLIC ACID | SYNTEX (U.S.A.) INC. (US) | 1994-01-20 | — | — | WO | claimed |
| US-5247083-A | Direct esterification of mycophenolic acid | SYNTEX (U.S.A.) INC. (US) | 1993-09-21 | — | — | US | claimed |